Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Anti-Human CDH11 Antibody (RG6125) | Login | Research Grade Anti-Human CDH11 Antibody (RG6125) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD136/MST1R Antibody (Aveo anti-RON) | Login | Research Grade Anti-Human CD136/MST1R Antibody (Aveo anti-RON) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human BACE1 Antibody (Genentech anti-BACE1) | Login | Research Grade Anti-Human BACE1 Antibody (Genentech anti-BACE1) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD167a/DDR1 Antibody (Imperial College anti-DDR1) | Login | Research Grade Anti-Human CD167a/DDR1 Antibody (Imperial College anti-DDR1) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human TGFBR2/TGFR-2 Antibody (LY3022859) | Login | Research Grade Anti-Human TGFBR2/TGFR-2 Antibody (LY3022859) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD309/KDR/VEGFR-2 Antibody (AT001) | Login | Research Grade Anti-Human CD309/KDR/VEGFR-2 Antibody (AT001) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD136/MST1R Antibody (H5B14) | Login | Research Grade Anti-Human CD136/MST1R Antibody (H5B14) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human NAMPT Antibody (Alt-100) | Login | Research Grade Anti-Human NAMPT Antibody (Alt-100) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human MAGEA4 & CD3 (Imc-C103C) | Login | Research Grade Anti-Human MAGEA4 & CD3 (Imc-C103C) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Cinrebafusp alfa | Login | Research Grade Cinrebafusp alfa | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD309/VEGFR2 Antibody (BC001) | Login | Research Grade Anti-Human CD309/VEGFR2 Antibody (BC001) | ||||||||||||||||
|
||||||||||||||||||
Enapotamab vedotin (ADC) | Login | Enapotamab vedotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Tilvestamab-MMAE (ADC) | Login | Tilvestamab-MMAE (ADC) | ||||||||||||||||
|
||||||||||||||||||
Vorsetuzumab mafodotin (ADC) | Login | Vorsetuzumab mafodotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Polatuzumab vedotin-piiq (ADC) | Login | Polatuzumab vedotin-piiq (ADC) | ||||||||||||||||
|
||||||||||||||||||
Iladatuzumab vedotin (ADC) | Login | Iladatuzumab vedotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Codrituzumab-MMAE (ADC) | Login | Codrituzumab-MMAE (ADC) | ||||||||||||||||
|
||||||||||||||||||
Zilovertamab vedotin (ADC) | Login | Zilovertamab vedotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Ozuriftamab vedotin (ADC) | Login | Ozuriftamab vedotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Danvilostomig | Login | Research Grade Danvilostomig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Volrustomig | Login | Research Grade Volrustomig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Rilvegostomig | Login | Research Grade Rilvegostomig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Zeripatamig | Login | Research Grade Zeripatamig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human KLB/Beta-klotho Antibody (MK-3655) | Login | Research Grade Anti-Human KLB/Beta-klotho Antibody (MK-3655) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Pembrolizumab | Login | Research Grade Pembrolizumab | ||||||||||||||||
|